Transcatheter closure of secundum atrial septal defect

Since the introduction of transcatheter closure of atrial septal defect, device closure has become the alternative treatment of selected atrial defects. Although excellent results have been reported for transcatheter closure, concerns have arisen regarding complications, including residual shunt, sy...

Full description

Saved in:
Bibliographic Details
Published in:General thoracic and cardiovascular surgery 2013-11, Vol.61 (11), p.614-618
Main Authors: Shimpo, Hideto, Hojo, Reina, Ryo, Maeshiro, Konuma, Takeshi, Tempaku, Hironori
Format: Article
Language:English
Subjects:
Age groups
Blood clots
Cardiac Catheterization
Cardiac Surgery
Cardiology
Current Topics Review Article
Embolization
FDA approval
Heart failure
Heart Septal Defects, Atrial - surgery
Humans
Length of stay
Medicine
Medicine & Public Health
Patient Selection
Patients
Prosthesis Implantation
Pulmonary arteries
Surgical Oncology
Thoracic Surgery
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Since the introduction of transcatheter closure of atrial septal defect, device closure has become the alternative treatment of selected atrial defects. Although excellent results have been reported for transcatheter closure, concerns have arisen regarding complications, including residual shunt, systemic or pulmonary embolization of the device, and erosion and perforation of the cardiac chamber. Those complications are rare but potentially serious adverse events that may require immediate surgical intervention. This review summarizes the current trends in patient selection, result of device closure and typical complications. Comparison between transcatheter device closure and surgical closure is also made.
ISSN:1863-6705
1863-6713
DOI:10.1007/s11748-013-0268-7